Ledger.Open graph →
SEC Form D · filed May 11, 2022

Tempest Therapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Thomas W. Woiwode · South San Francisco, CADirectorChristine W. Pellizzari · South San Francisco, CADirectorStephen R. Brady · South San Francisco, CAExec · DirectorMichael W. Raab · South San Francisco, CADirectorRonit W. Simantov · South San Francisco, CADirectorGeoffrey W. Nichol · South San Francisco, CADirectorThomas W. Dubensky · Berkeley, CAExec · DirectorStephen R. Brady · South San Francisco, CAExec · DirectorMichael W. Raab · South San Francisco, CADirectorRonit W. Simantov · South San Francisco, CADirectorThomas W. Woiwode · South San Francisco, CADirectorGeoffrey W. Nichol · South San Francisco, CADirectorThomas W. Dubensky · Berkeley, CAExec · DirectorChristine W. Pellizzari · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗